Omegaven Infusion

Introduction

Omegaven is a prescription medication that contains two active ingredients: Eicosapentaenoic acid and Docosahexanoic acid. It is available in the form of an infusion.

Uses

Omegaven is primarily prescribed for the management of certain conditions related to cardiovascular health. It is commonly used as an adjunct therapy in patients with hypertriglyceridemia, a condition characterized by high levels of triglycerides in the blood. This medication may also be recommended for individuals with severe hypertriglyceridemia associated with pancreatitis.

Dosage and Administration

The dosage and administration of Omegaven should be determined by a healthcare professional based on individual patient needs. It is typically administered as an intravenous infusion over a specific duration, as prescribed by the healthcare provider. The infusion is usually given in a healthcare setting under the supervision of a trained medical professional.

Mechanism of Action

Eicosapentaenoic acid and Docosahexanoic acid, the active ingredients in Omegaven, belong to a group of fatty acids known as omega-3 fatty acids. These fatty acids have been shown to have various beneficial effects on cardiovascular health. Eicosapentaenoic acid and Docosahexanoic acid work by reducing the production of triglycerides and certain inflammatory substances in the body. This can help improve lipid profiles and reduce the risk of cardiovascular events.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort. Inform your healthcare provider if any of these side effects persist or worsen.

Serious side effects are rare but may include allergic reactions, such as difficulty breathing, rash, or swelling of the face, lips, tongue, or throat. If you experience any of these symptoms, seek immediate medical attention.

Drug Interactions

Omegaven may interact with certain medications. Inform your healthcare provider about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. Some medications, such as anticoagulants or antiplatelet drugs, may increase the risk of bleeding when taken concomitantly with Omegaven. Your healthcare provider will closely monitor your medication regimen to minimize the risk of interactions.

Precautions

Before using Omegaven, inform your healthcare provider about any existing medical conditions, including allergies, liver disease, or bleeding disorders. This medication should be used with caution in patients with a history of bleeding disorders. Avoid alcohol consumption while using Omegaven, as it may increase the risk of bleeding.

Storage

Omegaven should be stored as directed by the healthcare provider or pharmacist. It is typically stored in a cool, dry place away from direct sunlight and heat. The medication should be kept out of the reach of children and pets.

Patient Tips

• Follow the dosage instructions provided by your healthcare provider. Do not change the dose or duration of treatment without consulting your healthcare provider.
• If you have any questions or concerns about the medication or its administration, do not hesitate to reach out to your healthcare provider or pharmacist.
• Report any side effects or unusual symptoms to your healthcare provider promptly.
• Attend all scheduled follow-up visits with your healthcare provider to monitor your response to the medication.
• Store the medication properly and discard any unused medication as per your healthcare provider’s instructions.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Isovaleric acidaemia (NHS UK) [Accessed 16 Jun. 2024] (online) Available at:
• Bempedoic Acid: Uses, Dosage, Side Effects, Warnings Consumer Information (Drugs.com) [Accessed 28 Jun. 2024] (online) Available at:
• docosahexanoic acid-epa capsule () [Accessed 26 Jun. 2024] (online) Available at:
• Comitini F, Peila C, Fanos V, Coscia A. The Docosahexanoic Acid: From the Maternal-Fetal Dyad to Early Life Toward Metabolomics. Front Pediatr. 2020 Sep 30;8:538. doi: 10.3389/fped.2020.00538. eCollection 2020. [Accessed 4 Jun. 2024] Available at: